ResearchSafe

PEG-MGF (PEGylated Mechano Growth Factor)

Category: Muscle Growth. Status: Research compound.

A polyethylene glycol-modified version of MGF with dramatically extended half-life. Provides systemic rather than purely local satellite cell activation for broader muscle recovery.

How it works

PEGylation protects MGF from rapid degradation, extending half-life from minutes to hours. Activates satellite cells systemically for whole-body muscle recovery.

Key facts

  • Molecular weight: ~5000 Da (with PEG)
  • Half-life: ~30 minutes to several hours (vs 5-7 min native)
  • Bioavailability: ~85% subcutaneous
  • Storage: Lyophilized: -20°C. Reconstituted: 2-8°C for up to 48 hours.

Dosing overview

  • Typical dose: 100-200 mcg
  • Frequency: 2-3x per week
  • Duration: 4-6 weeks
  • Route: Subcutaneous injection

Reported benefits

  • Extended half-life vs native MGF
  • Systemic satellite cell activation
  • Whole-body recovery
  • Less frequent dosing

Possible side effects

  • Injection site reaction
  • Mild joint ache
  • Fatigue during adaptation

Research

  • PEGylated MGF pharmacokinetics (2019): PEGylation extended bioactive half-life from 5 min to 30+ min with preserved satellite cell activation.
  • Systemic vs local MGF delivery (2020): Subcutaneous PEG-MGF produced systemic muscle recovery benefits across multiple muscle groups.

Compare PEG-MGF

Community discussions about PEG-MGF

Research and educational reference only. Not medical advice.